ELECTROCORE INC(NASDAQ:ECOR) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ECOR. ECOR was compared to 190 industry peers in the Health Care Equipment & Supplies industry. While ECOR seems to be doing ok healthwise, there are quite some concerns on its profitability. ECOR shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

ECOR had negative earnings in the past year.

ECOR had a negative operating cash flow in the past year.

In the past 5 years ECOR always reported negative net income.

ECOR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -58.06%, ECOR is not doing good in the industry: 71.58% of the companies in the same industry are doing better.

With a Return On Equity value of -157.56%, ECOR is not doing good in the industry: 69.47% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-58.06%
ROE	-157.56%
ROIC	N/A

ROA(3y)-88.18%

ROA(5y)-75.86%

ROE(3y)-180.1%

ROE(5y)-137.89%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 84.97%, ECOR belongs to the top of the industry, outperforming 95.79% of the companies in the same industry.

ECOR's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for ECOR so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	84.97%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y4.4%

GM growth 5Y10.55%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ECOR does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ECOR has been increased compared to 1 year ago.

ECOR has more shares outstanding than it did 5 years ago.

ECOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -10.41, we must say that ECOR is in the distress zone and has some risk of bankruptcy.

ECOR's Altman-Z score of -10.41 is on the low side compared to the rest of the industry. ECOR is outperformed by 76.84% of its industry peers.

There is no outstanding debt for ECOR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-10.41

ROIC/WACCN/A

WACC8.98%

2.3 Liquidity

A Current Ratio of 1.78 indicates that ECOR should not have too much problems paying its short term obligations.

ECOR has a worse Current ratio (1.78) than 68.95% of its industry peers.

ECOR has a Quick Ratio of 1.60. This is a normal value and indicates that ECOR is financially healthy and should not expect problems in meeting its short term obligations.

ECOR's Quick ratio of 1.60 is in line compared to the rest of the industry. ECOR outperforms 43.68% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.78
Quick Ratio	1.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ECOR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.78%, which is quite impressive.

Looking at the last year, ECOR shows a very strong growth in Revenue. The Revenue has grown by 57.08%.

ECOR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 60.15% yearly.

EPS 1Y (TTM)54.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%34.43%

Revenue 1Y (TTM)57.08%

Revenue growth 3Y66.56%

Revenue growth 5Y60.15%

Sales Q2Q%35.73%

3.2 Future

Based on estimates for the next years, ECOR will show a very strong growth in Earnings Per Share. The EPS will grow by 41.66% on average per year.

ECOR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.84% yearly.

EPS Next Y20.36%

EPS Next 2Y43.43%

EPS Next 3Y41.66%

EPS Next 5YN/A

Revenue Next Year29.95%

Revenue Next 2Y37.87%

Revenue Next 3Y37.45%

Revenue Next 5Y21.84%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ECOR. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ECOR. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ECOR's earnings are expected to grow with 41.66% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y43.43%

EPS Next 3Y41.66%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ECOR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ELECTROCORE INC

NASDAQ:ECOR (4/17/2025, 8:14:42 PM)

After market: 6.02 0 (0%)

6.02

+0.04 (+0.67%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)03-12 2025-03-12/amc

Earnings (Next)05-06 2025-05-06/amc

Inst Owners18.95%

Inst Owner Change0%

Ins Owners18.26%

Ins Owner Change0.65%

Market Cap43.28M

Analysts83.64

Price Target25.7 (326.91%)

Short Float %2.5%

Short Ratio0.86

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-9.23%

Min EPS beat(2)-27.74%

Max EPS beat(2)9.28%

EPS beat(4)3

Avg EPS beat(4)3.55%

Min EPS beat(4)-27.74%

Max EPS beat(4)17.87%

EPS beat(8)5

Avg EPS beat(8)-0.84%

EPS beat(12)5

Avg EPS beat(12)-4.22%

EPS beat(16)8

Avg EPS beat(16)1.82%

Revenue beat(2)0

Avg Revenue beat(2)-1.53%

Min Revenue beat(2)-2.02%

Max Revenue beat(2)-1.04%

Revenue beat(4)2

Avg Revenue beat(4)4.31%

Min Revenue beat(4)-2.02%

Max Revenue beat(4)11.95%

Revenue beat(8)4

Avg Revenue beat(8)3.45%

Revenue beat(12)7

Avg Revenue beat(12)2.42%

Revenue beat(16)8

Avg Revenue beat(16)1.38%

PT rev (1m)2.86%

PT rev (3m)-7.01%

EPS NQ rev (1m)-17.76%

EPS NQ rev (3m)-97.6%

EPS NY rev (1m)-137.17%

EPS NY rev (3m)-114.63%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-13.89%

Revenue NY rev (1m)-6.16%

Revenue NY rev (3m)-6.16%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.72
P/FCF	N/A
P/OCF	N/A
P/B	5.74
P/tB	5.74
EV/EBITDA	N/A

EPS(TTM)-1.61

EYN/A

EPS(NY)-1.28

Fwd EYN/A

FCF(TTM)-0.97

FCFYN/A

OCF(TTM)-0.97

OCFYN/A

SpS3.5

BVpS1.05

TBVpS1.05

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-58.06%
ROE	-157.56%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	84.97%
FCFM	N/A

ROA(3y)-88.18%

ROA(5y)-75.86%

ROE(3y)-180.1%

ROE(5y)-137.89%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y4.4%

GM growth 5Y10.55%

F-Score6

Asset Turnover1.23

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	0%
Cap/Sales	0%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.78
Quick Ratio	1.6
Altman-Z	-10.41

F-Score6

WACC8.98%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)54.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%34.43%

EPS Next Y20.36%

EPS Next 2Y43.43%

EPS Next 3Y41.66%

EPS Next 5YN/A

Revenue 1Y (TTM)57.08%

Revenue growth 3Y66.56%

Revenue growth 5Y60.15%

Sales Q2Q%35.73%

Revenue Next Year29.95%

Revenue Next 2Y37.87%

Revenue Next 3Y37.45%

Revenue Next 5Y21.84%

EBIT growth 1Y36.91%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year83.42%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y53.29%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y52.63%

OCF growth 3YN/A

OCF growth 5YN/A

ELECTROCORE INC (ECOR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens